Overall, we propose a model where activation of AKT through PTEN KD induces EZH2 phosphorylation at serine 21, which attenuates PRC2 activity, and enhances the transcriptional activity of AP1 to transcriptionally reprogram epithelial CRC cells toward mesenchymal cells (Fig 6E). The gene discussed is FOS; the disease is colorectal carcinoma.